Search results
Signs and Symptoms of Diabetes in Men
Health via Yahoo News· 2 days agoMedically reviewed by Kelly Wood, MD Diabetes is a condition that causes an imbalance in blood sugar due to problems with how the body makes or responds...
New study shows NHS digital weight management program is effective at achieving clinically...
Medical Xpress· 11 hours agoThe success of a national weight management program has been highlighted in a study in the journal...
Tandem Diabetes Care Shares Rise 17% on Raised 2024 Sales Outlook
Market Watch· 17 hours agoBy Denny Jacob Tandem Diabetes Care shares rose 17% in premarket trading after it bumped up its adjusted sales outlook for 2024. Shares were trading around...
7-Day No-Sugar Vegetarian Meal Plan for Diabetes, Created by a Dietitian
Eating Well via Yahoo News· 6 days agoReap the benefits of a vegetarian diet while skipping added sugars in this delicious meal plan for ...
Novo Nordisk A/S (NYSE:NVO) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 9 hours agoNovo Nordisk A/S (NYSE:NVO) Q1 2024 Earnings Call Transcript May 2, 2024 Novo Nordisk A/S misses on...
Tandem Diabetes Care Inc (TNDM) Q1 2024 Earnings: Outperforms Revenue Estimates and Updates ...
GuruFocus.com via Yahoo Finance· 1 day agoProduct Launches: Launched new insulin pump models and integrations in the U.S. and began international rollout, enhancing product portfolio and market reach. On May 2, 2024, Tandem
Denmark to restrict Ozempic, other GLP-1 drugs, to treat type 2 diabetes
Reuters via Yahoo News· 3 days agoDenmark will start putting patients suffering from type 2 diabetes on cheaper drugs before...
Novo nabs over a third of diabetes market, a year ahead of schedule
Endpoints News· 1 day agoNovo Nordisk’s GLP-1 drugs may have been the center of attention during its first-quarter earnings...
I Tried Sleeping Tight With Lemme Sleep. Here's What Happened
CNET· 9 hours agoIt’s no secret that sleep is essential to our well-being. Long-term sleep deprivation can have...
This Is a Huge Sigh of Relief for Novo Nordisk Investors
Motley Fool via Yahoo Finance· 17 hours agoNovo Nordisk's (NYSE: NVO) success hinges on two key products: Ozempic and Wegovy. The former is a ...